Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial coiled-coil domain 1 pseudogene 2 (MCCD1P2) is a processed human pseudogene with high sequence similarity to the parent MCCD1 gene, lacking protein-coding capability. Pseudogenes are genomic elements once considered nonfunctional, but emerging evidence indicates some may regulate gene expression, particularly through RNA-based mechanisms such as acting as microRNA decoys or producing small regulatory RNAs. The specific function and biological significance of MCCD1P2 are currently undetermined; it is not a conventional therapeutic target and is not associated with known interacting drugs, biomarker roles, or safety concerns. Recent studies highlight a small subset of pseudogenes with cell-type or disease-specific regulatory functions, particularly in cancer and complex disease contexts, mainly through miRNA competition or transcriptional modulation, but these findings do not extend to MCCD1P2 based on available data[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial coiled-coil domain 1 pseudogene 2 (MCCD1P2).